1x WGS
Low-pass whole genome sequencing for large-scale population studies and screening programs.
- Cost-effective at scale
- Imputation-ready output
- Ideal for biobanks & cohort studies

Business & Enterprise
Trusted by leading research institutions, pharma, and biotech companies for whole genome sequencing services.
Get in touch99%+
of DNA sequenced
600+
peer-reviewed publications
100K+
genomes processed
CLIA
certified U.S. laboratory
From low-pass screening to ultra-deep oncology sequencing, Nebula Genomics offers flexible whole genome sequencing tiers to match your research goals and budget. All processing takes place in our U.S.-based, CLIA-certified laboratory.
Low-pass whole genome sequencing for large-scale population studies and screening programs.
Clinical-grade whole genome sequencing — the gold standard for research and diagnostic applications.
Ultra-deep sequencing for somatic mutation detection, oncology research, and rare variant discovery.
From initial consultation to secure data delivery, our streamlined process is designed for enterprise reliability and scientific rigor.
Speak with our sequencing experts to define your project scope, sample requirements, and deliverables.
We provide collection kits and logistics support. Saliva or blood samples — we handle the chain of custody.
Samples are processed in our U.S.-based laboratory with rigorous quality control at every stage.
Receive CRAM, VCF, and FASTQ files via secure transfer. Optional bioinformatics analysis and reporting.
Whether you're running clinical trials, powering academic research, or deploying population-scale screening, our platform adapts to your workflow.
Accelerate drug discovery and clinical trials with genomic data from sponsored sequencing programs. Participants receive their data at no cost while sponsors gain research-grade insights.
Power observational studies, longitudinal cohorts, and multi-omics research with whole genome data from our U.S.-based CLIA-certified laboratory.
Integrate whole genome sequencing into clinical workflows for rare disease diagnosis, pharmacogenomics, and hereditary cancer screening.
Deploy large-scale genomic screening programs for health systems, governments, and public health initiatives with cost-effective low-pass sequencing.
Sponsored Sequencing
With Nebula's sponsored sequencing program, research sponsors fund whole genome sequencing for study participants. Participants receive their complete genomic data and personalized reports at no cost, while sponsors gain access to de-identified, research-grade data — creating a win-win for science and individuals.
Access large-scale, high-quality genomic datasets for drug discovery, biomarker identification, and population studies.
Receive free whole genome sequencing, personalized health reports, and full ownership of your genomic data.
Accelerate research timelines, increase participant engagement, and build diverse genomic cohorts at scale.

Get started
Our sequencing experts offer free consultations to help you define project scope, sample logistics, and data deliverables. Reach out and let's build something together.
Contact usOr email us directly at business@nebula.org
Unlike traditional DNA tests that analyze only a small portion of your genome, DNA Complete sequences 100% of your DNA, revealing deeper insights into health, traits, ancestry, and new genetic discoveries.

